Box score
Vesalius Longevity Labs (SPV) Inc.
Reported $6.7M sold in a new Form D filed March 19, 2026 (Vancouver, outside the US).
- Biggest raise
- $6.7M filed Mar 19, 2026
- League
- Bio & Health Biotechnology
- Based in
- Vancouver, outside the US
- Season rank
- #269 of 1,121 in the Bio & Health League; #2354 of 10,745 overall (2026)
- Incorporated
- 2024
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-03-19 | New notice | $6.7M | $6.7M | SEC |
| 2025-05-13 | New notice | $250K | $250K | SEC |
| 2025-03-27 | New notice | $895K | $895K | SEC |
| 2025-02-19 | New notice | $1.7M | $1.7M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2056924.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Can-Fite BioPharma Ltd. | Bio & Health | $8.3M |
| 2 | Pulsenmore Ltd. rookie provisional | Bio & Health | $7.5M |
| 3 | Regentis Biomaterials Ltd. rookie | Bio & Health | $6.5M |
| 4 | Federated Biologics Inc. rookie | Bio & Health | $6M |
| 5 | EnteroBiotix LTD | Bio & Health | $5.3M |
| 6 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |